weight loss maintenance after semaglutide Teaching obesity/weight management this week for our P2s, so here's a post on incretin therapy for loss! 💊 Incretin-based therapy, including the GLP-1 agonists liraglutide and and the GLP-1/GIP dual Weight loss results after 8

Dried Blood Spot Testing Some functional medicine practitioners use dried blood spot kits that can be used at home

It is associated in published preclinical literature with collagen and decorin regulation and broad gene-expression shifts in ECM-related markers

Outcomes Primary and Secondary Outcome Patients in the semaglutide study arm experienced a significantly lower rate of the primary outcome (cardiovascular composite end-point) (6.5% vs 8.0%, HR 0.80 (95% CI 0.72-0.90) No significant difference in rates of cardiac death (HR 0.85, 95% CI 0.71-1.01) however significantly lower rates of heart failure (HR 0.82, 95% CI 0.71-0.96) and all-cause mortality (HR 0.81, 95% CI 0.71-0.93) Adverse Events Rates and types of adverse events were fairly similar between control and intervention groups Permanent premature discontinuation of semaglutide or placebo occurred in 2351 patients (26.7%) in the semaglutide group and 2078 (23.6%) in the placebo group In obese and overweight patients with cardiovascular comorbidities but without diabetes, treatment with weekly semaglutide was superior to placebo in reducing the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke at a mean follow-up of 39.8 months

doi: 10.1185/03007995.2015.1103214

Potential Benefits: Healthy weight loss Appetite control Balanced glucose levels Reduced cravings Cardio-protection Decreased blood pressure Semaglutide is a once-weekly injection that helps control blood sugar levels in adults with Type 2 Diabetes